Picture of Elutia logo

ELUT — Elutia News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Aziyo Biologics Anticipates Q4 2022 Net Sales of About $12.5 Mln to $12.7 Mln

Jan 9 (Reuters) - Aziyo Biologics Inc  AZYO.O :
    * AZIYO BIOLOGICS ANNOUNCES RECORD ANNUAL NET SALES IN
PRELIMINARY
(UNAUDITED) FOURTH QUARTER AND FULL YEAR 2022 TOPLINE RESULTS
    * AZIYO BIOLOGICS INC - ANTICIPATE Q4 2022 NET SALES OF
APPROXIMATELY $12.5-$12.7 MILLION, AN INCREASE OF 15%-17%
COMPARED TO SAME PRIOR YEAR PERIOD
    * AZIYO BIOLOGICS INC - ANTICIPATE Q4 2022 NET SALES OF
APPROXIMATELY $12.5-$12.7 MILLION, AN INCREASE OF 15%-17%
    * AZIYO BIOLOGICS INC  - ANTICIPATE FULL YEAR 2022 RECORD
NET
SALES OF APPROXIMATELY $49.0-$49.2 MILLION, AN INCREASE OF 3%-4%
COMPARED TO PRIOR YEAR

Source text for Eikon:  ID:nGNX1DFtqp 
Further company coverage:  AZYO.O 
 ((reuters.briefs@thomsonreuters.com;))

Recent news on Elutia

See all news